The results of a study in Nature demonstrate that intranasal administration of an engineered IgM neutralizing antibody can improve efficacy, reduce resistance, and simplify the prophylactic and therapeutic treatment of COVID-19.
Every way we look at it, Covid-19 presents us with new challenges and repercussions.
BBC reports an MP, Layla Moran, talking about the staggering number of “long covid” cases in the UK. As per her estimates, current numbers are crossing 300,000 patients.
With such a large number of patients, it is important to recognize this as an “occupational disease”. Now, in practice, what this really means is that around half of the hospitalized patients would still exhibit symptoms as long as six months since the first onset of the disease.
On the other hand, from the people who did not get hospitalized, 10% would still show the symptoms after 3 months.
While the UK has reacted by establishing 10 more “Long covid” clinics, other countries are not being that proactive.
- Staggering number of long covid cases. Link